New from NICE

Tolvaptan for treating autosomal dominant polycystic kidney disease Tolvaptan (Jinarc) is a selective vasopressin V2 antagonist, which reduces cell proliferation, cyst formation and fluid excretion, reducing kidney growth and protecting kidney function.

New from NICE

Add yours ↓
Web design and marketing agency Leamington Spa